Brief: Biosergen Gets Regulatory Approval To Test Lead Candidate BSG005 In Patients With Invasive Fungal Infection
12/02/2024 14:15
Feb 12 (Reuters) - Biosergen AB BIOSGN.ST :
* BIOSERGEN RECEIVES REGULATORY APPROVAL TO TEST LEAD
CANDIDATE
BSG005 IN PATIENTS WITH INVASIVE FUNGAL INFECTION
Source text for Eikon: ID:nWkrVSM7F
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))